Beacon
Gregory Kavalerov is a data scientist currently employed at Albert Heijn since May 2024 and previously worked as a data consultant at Ogham Analytics BV, specializing in customer analytics. Gregory has a diverse background in data roles at Hanson Wade Group, where responsibilities included data scientist, account manager, account executive, and delegate acquisition manager from November 2018 to November 2023. A machine learning internship at Carbon Re and earlier positions in customer service and research further complemented Gregory's experience. Gregory holds a Master of Science in Energy Systems & Data Analytics from UCL (September 2022 - September 2023) and a Bachelor's degree in Medicinal Chemistry from Trinity College Dublin (2014 - 2018).
This person is not in any offices
Beacon
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape. With Beacon, you can make drug development decisions with confidence. This is why 23 out of the world’s top 25 drug developers trust us.